WHO declares a “public health emergency” for ten years
According to the press release issued at 9:31 a.m. this morning by the World Health Organization.
It is linked here:
https://www.who.int/initiatives/genomic-surveillance-strategy
What does that mean?
It means that since March 10th, under International Law, 18 organizations have control of 196 governments to conduct “genomic surveillance as a global public good”.
They are only accountable to themselves.
They are:
Page 18 of 21 pages adopted on March 10th
https://apps.who.int/iris/bitstream/handle/10665/352580/9789240046979-eng.pdf?sequence=1&isAllowed=y
What exactly does “genomic surveillance as a global public good” mean?
Whatever the gang of 18 decides.
It has ten guidelines linked above.
On Friday, they were ratified by a committee of 20 persons.
Committee members are:
Preben Aavitsland
Senior Consultant, Professor, Domain for infectious disease prevention, health and the environment, Norwegian Institute of Public Health, Oslo, Norway
Ximena Aguilera
Director of Center of Epidemiology and Health Policy, Faculty of Medicine at Universidad del Desarrollo, Chile
Seif Salam Al-Abri
Director-General for Disease Surveillance and Control at the Ministry of Health of Oman
Vincent Anami
Continent Representative (Africa), Center for Disaster and Humanitarian Assistance Medicine, Uniformed Services University of the Health and Sciences, Friends International Centre, Nairobi, Kenya
Thuraya Annabi Attia
Former Director of the Food Safety Department at The National Agency of Sanitary and Environmental Control of Products, Ministry of Health, Tunisia
Carmen Aramburu
Director of Health and Social Policy, Delegation of the Spanish Government in Catalonia, Spain
Lucille Blumberg
Deputy Director, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa
Malinee Chittaganpitch
Medical Scientist Advisor, Department of Medical Sciences, MoPH Thailand
James LeDuc
Director, Galveston National Laboratory, University of Texas Medical Branch, United States of America
Dexin Li
Former Director, National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, People’s Republic of China
Rinat Maksyutov
Director-General, Federal Budgetary Research Institution - State Research Center of Virology and Biotechnology VECTOR, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Russian Federation
Talat Mokhtari Azad
Director, Iranian National Influenza Center, Department, Tehran University of Medical Sciences, School of Public Health, Tehran, Islamic Republic of Iran
Mohamed Massif
Chief of Public Health, Mohammad V International Airport, and National Coordinator of the Points of Entry Program, Morocco
Olubunmi Ojo
Director of International Health Regulations at the National Public Health Institute, Nigeria
Jean-Marie Okwo-Bele
Former Director of the Vaccines and Immunization Department, WHO headquarters, Geneva, Switzerland
Tomoya Saito
Director, Center for Emergency Preparedness and Response National Institute of Infectious Diseases, Japan
Amadou Alpha Sall
Director of Institut Pasteur de Dakar and WHO Collaborating Center for Arboviruses and Viral Hemorrhagic Fevers, Senegal
Mark Salter
Consultant in Global Health, Public Health England, London, United Kingdom of Great Britain and Northern Ireland
Professor Myongsei Sohn
Professor Emeritus, College of Medicine, Yonsei University, Republic of Korea
Lothar H. Wieler
President of the Robert Koch Institute, GERMANY
https://www.who.int/teams/ihr/ihr-review-committees/covid-19
Related story
Tedros “shall” supersede U.S. law after declaring a “public health emergency”
Tip from Kevin Mooring
